ArticleClinical cancer research : an official journal of the American Association for Cancer Research2008

A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.

Emilian Racila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.